134 related articles for article (PubMed ID: 20336771)
1. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
[TBL] [Abstract][Full Text] [Related]
2. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.
Fischer DF; De Vos RA; Van Dijk R; De Vrij FM; Proper EA; Sonnemans MA; Verhage MC; Sluijs JA; Hobo B; Zouambia M; Steur EN; Kamphorst W; Hol EM; Van Leeuwen FW
FASEB J; 2003 Nov; 17(14):2014-24. PubMed ID: 14597671
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
[TBL] [Abstract][Full Text] [Related]
4. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW
Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
[TBL] [Abstract][Full Text] [Related]
5. Conformational diseases: an umbrella for various neurological disorders with an impaired ubiquitin-proteasome system.
de Pril R; Fischer DF; van Leeuwen FW
Neurobiol Aging; 2006 Apr; 27(4):515-23. PubMed ID: 16226348
[TBL] [Abstract][Full Text] [Related]
6. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates.
Verhoef LG; Heinen C; Selivanova A; Halff EF; Salomons FA; Dantuma NP
FASEB J; 2009 Jan; 23(1):123-33. PubMed ID: 18796559
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer-associated mutant ubiquitin impairs spatial reference memory.
van Tijn P; Hobo B; Verhage MC; Oitzl MS; van Leeuwen FW; Fischer DF
Physiol Behav; 2011 Feb; 102(2):193-200. PubMed ID: 21059367
[TBL] [Abstract][Full Text] [Related]
8. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
[TBL] [Abstract][Full Text] [Related]
9. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.
De Vrij FM; Sluijs JA; Gregori L; Fischer DF; Hermens WT; Goldgaber D; Verhaagen J; Van Leeuwen FW; Hol EM
FASEB J; 2001 Dec; 15(14):2680-8. PubMed ID: 11726544
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).
Rockwell P; Yuan H; Magnusson R; Figueiredo-Pereira ME
Arch Biochem Biophys; 2000 Feb; 374(2):325-33. PubMed ID: 10666314
[TBL] [Abstract][Full Text] [Related]
11. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.
Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J
Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000
[TBL] [Abstract][Full Text] [Related]
12. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.
de Pril R; Fischer DF; Maat-Schieman ML; Hobo B; de Vos RA; Brunt ER; Hol EM; Roos RA; van Leeuwen FW
Hum Mol Genet; 2004 Aug; 13(16):1803-13. PubMed ID: 15198995
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
Menéndez-Benito V; Verhoef LG; Masucci MG; Dantuma NP
Hum Mol Genet; 2005 Oct; 14(19):2787-99. PubMed ID: 16103128
[TBL] [Abstract][Full Text] [Related]
15. Molecular misreading: the occurrence of frameshift proteins in different diseases.
van Leeuwen FW; Kros JM; Kamphorst W; van Schravendijk C; de Vos RA
Biochem Soc Trans; 2006 Nov; 34(Pt 5):738-42. PubMed ID: 17052186
[TBL] [Abstract][Full Text] [Related]
16. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
17. Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model.
de Pril R; Hobo B; van Tijn P; Roos RA; van Leeuwen FW; Fischer DF
Mol Cell Neurosci; 2010 Mar; 43(3):281-6. PubMed ID: 20005957
[TBL] [Abstract][Full Text] [Related]
18. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
van Leeuwen FW; Hol EM; Fischer DF
J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
[TBL] [Abstract][Full Text] [Related]
19. Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B.
Gerez L; de Haan A; Hol EM; Fischer DF; van Leeuwen FW; van Steeg H; Benne R
Neurobiol Aging; 2005 Feb; 26(2):145-55. PubMed ID: 15582744
[TBL] [Abstract][Full Text] [Related]
20. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1.
Nie J; Wu M; Wang J; Xing G; He F; Zhang L
FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
